Schedule 13G ownership disclosure

TRAWS PHARMA INC

Common Stock, par value $.01 per share · CUSIP: 68232V884

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 713,540.00 · Class: 8.9%

  • Squadron Capital Management LLC

    Shares: 713,540.00 · Class: 8.9%

  • Matthew Sesterhenn

    Shares: 713,540.00 · Class: 8.9%

  • William Blank

    Shares: 713,540.00 · Class: 8.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-26-000009
Form type
SCHEDULE 13G/A
Filer
Squadron Capital Management LLC
CIK
CIK 2050709
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub